Latham BioPharm Group Awarded NIAID Preclinical Services IDIQ Contract Valued at Up to $30 Million
Latham BioPharm Group, part of SIA Partners, today announced receiving a new Indefinite Delivery, Indefinite Quantity (IDIQ) contract award from the National Institute of Allergy and...